切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2009, Vol. 03 ›› Issue (05) : 487 -495. doi: 10.3877/cma.j.issn.1674-0807.2009.05.005

专家论坛

18F-FDG PET/CT诊断乳腺癌及其腋窝淋巴结转移的价值评价
朱湘1, 徐文贵1,(), 马文超1, 戴东1, 朱磊1, 宋秀宇1, 朱研佳1, 王健1, 门晓媛1   
  1. 1.300060 天津,天津医科大学附属肿瘤医院PET-CT中心
  • 收稿日期:2009-05-11 出版日期:2009-10-01
  • 通信作者: 徐文贵
  • 基金资助:
    国家自然科学基金项目(30872954)天津市自然科学基金重点项目(08JCZDJC23700)天津市科委面上项目(07JCYBJC09300)

Value of 18 F-FDG PET/CT imaging in the detection of breast cancer and axillary lymph node metastases

Xiang ZHU1, Wen-gui XU,1(), Wen-chao MA1, Dong DAI1, Lei ZHU1, Xiu-yu SONG1, Yan-jia ZHU1, Jian WANG1, Xiao-yuan MEN1   

  1. 1.Department of PET-CT,Cancer Institute and Hospital,Tianjin Medical University Tianjin 300060,China
  • Received:2009-05-11 Published:2009-10-01
  • Corresponding author: Wen-gui XU
引用本文:

朱湘, 徐文贵, 马文超, 戴东, 朱磊, 宋秀宇, 朱研佳, 王健, 门晓媛. 18F-FDG PET/CT诊断乳腺癌及其腋窝淋巴结转移的价值评价[J/OL]. 中华乳腺病杂志(电子版), 2009, 03(05): 487-495.

Xiang ZHU, Wen-gui XU, Wen-chao MA, Dong DAI, Lei ZHU, Xiu-yu SONG, Yan-jia ZHU, Jian WANG, Xiao-yuan MEN. Value of 18 F-FDG PET/CT imaging in the detection of breast cancer and axillary lymph node metastases[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2009, 03(05): 487-495.

目的

探讨18 F-脱氧葡萄糖(18 F-FDG)在诊断乳腺癌及腋窝淋巴结转移的价值。

方法

对34例乳腺癌患者的乳腺病灶(以健侧为对照)及腋窝淋巴结18 F-FDG PET/CT显像结果进行定性分析和半定量分析,结合病理结果,计算两种方法诊断的灵敏度、特异度、准确性。两种方法诊断与病理诊断行一致性检验。对乳腺病灶恶性组及对照组组间最大标准化摄取值(SUVmax)均数的比较采用两独立样本t检验。

结果

两组间SUVmax均数比较显示:恶性组18 F-FDG摄取高于对照组,差异有统计学意义(P=0.00)。1例为大汗腺导管内癌,系原位癌,对18F-FDG摄取不明显,PET/CT图像上未见明显结节影,目测显示0级,SUVmax为1.5。该例病灶微小,小于PET/CT 5~8 mm 的分辨率,造成定性和半定量分析均漏诊。18F-FDG PET/CT 定性分析诊断乳腺癌的灵敏度、特异度、准确性分别为97.7%、100.0%、97.9%;半定量分析以SUVmax 2.0时,诊断乳腺癌的灵敏度、特异度、准确性为佳,分别为93.2%、100.0%、93.6%。定性分析与病理诊断的一致性极好,Kappa值为0.85,半定量分析与病理诊断有较好一致性,Kappa值为0.64。在腋窝淋巴结转移的诊断上,定性分析的诊断灵敏度、特异度、准确性分别为55.9%、96.1%、90.1%,半定量分析(以文献SUVmax 1.8为标准)的诊断灵敏度、特异度、准确性分别为45.8%、97.0%、89.3%。两种分析诊断与病理诊均较好一致性,Kappa值分别为0.57(定性分析)和0.51(半定量分析)。

结论

18 F-FDG PET/CT诊断乳腺恶性病灶时,以SUVmax 2.0为临界值进行半定量分析诊断具有较好的诊断价值;在诊断腋窝淋巴结转移方面,定性分析和半定量分析与病理诊均有较好的一致性。

Objective

To investigate the value of 18F-fluorodeoxyglucose(FDG)PET/CT i maging in diagnosis of breast cancer and axillary ly mph node metastases.

Methods

According to the pathological diagnostic results 34 breast cancer patients were recruited for the study.Their 18F-FDG PET/CT i maging data were analyzed qualitatively by visual assess ment and semi-quantitatively by calculating maxi mu m standardized uptake values(SUVmax).The sensitivity,specificity and accuracy of the t wo methods were measured,Kappa test was used for the consistency of each of the t wo PET/CT diagnostic methods with pathological diagnosis,and the mean of SUVmax bet ween groups was compared using t wo independent samples t test.

Results

The comparison of the mean SUVmax bet ween the 2 groups showed the 18 F-FDGuptake was greater in the malignant breast lesion group than in the control group,with statistical significant difference bet ween the three groups(P=0.00).One case of pathological apocrine intraductal carcino ma,cancer in situ,was negatively uptaken by PET/CT.The qualitative analysis showed zero grade and semiquantitative analysis showed SUVmax as 1.5,because the lesion size was so s mall,<5-8 c m,which was beyond the uptake range of PET/CT.In diagnosing breast malignancy,the diagnostic accuracy,sensitivity and specificity of 18 F-FDG PET/CT qualitative analysis was 97.9%,97.7%and 100.0%,respectively;for the semi-quantitative analysis,when the cut-off point of SUVmax was set at 2.0,the sensitivity,specificity,and accuracy was 93.2%,100.0% and 93.6%,respectively.The kappa value was 0.85 for qualitative analysis,with excellent agreement,and 0.64 for semi-quantitatively.In detecting axillary ly mph node metastases,the sensitivity,specificity,and accuracy of qualitative analysis were 55.9%,96.1%and 90.1%,respectively;for semi-quantitative analysis,the cut-off point of SUVmax was set at 1.8 (referenced to literature),the sensitivity,specificity,and accuracy were 45.8%,97.0%and 89.3%,respectively;the kappa value was 0.57 for the qualitative analysis and 0.51 for semi-quantitative analysis.

Conclusion

For detecting malignant breast lesions with 18 F-FDGPET/CT,when the cut-off point of SUVmax was set at 2.0,semi-quantitative analysis is opti mal.For detecting axillary ly mph node metastases,both qualitative analysis(Kappa value=0.57)and semi-quantitative analysis(Kappa value=0.51)have median agreement with pathological diagnosis.

图1 右乳腺PET/CT 图像 a:CT 图像示右乳可见局限结节致密影;b:PET 图像;c:PET/CT 融合图,均见结节样异常放射性浓聚影,经病理检查证实为非特殊型浸润性导管癌;双侧腋下未见明显结节及异常放射性浓聚影,病理诊断右侧腋下无转移淋巴结。
表1 PET/CT 定性分析法诊断乳腺癌病灶及腋窝淋巴结转移的结果及其评价指标
表2 PET/CT 半定量分析法诊断乳腺癌病灶及腋窝淋巴结转移的结果及其评价指标
表3 两组间SUVmax比较
表4 PET/CT 与病理诊断乳腺癌病灶的结果比较
表5 PET/CT与病理诊断腋窝淋巴结转移的结果比较
图2 左乳腺PET/CT 图像 a:CT 图像示左侧内乳区淋巴结显示不明显;b:PET 图像;c:PET/CT 融合图,可见明显结节样异常放射性浓聚;左侧胸大肌与胸小肌间淋巴结在CT、PET及PET/CT融合图相应显像(如a、b及c);左侧乳腺针吸病理结果是浸润性癌
[1]
潘中允.PET 诊断学.北京:人民卫生出版社,2005:202.
[2]
邹海东,马榕,余之刚,等.PET/CT 诊断乳腺癌及腋窝淋巴结状态的作用评价.外科理论与实践,2006,11:108-111.
[3]
Wahl R L,Siegel B A,Coleman R E,et al.Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer:a report of the staging breast cancer with PET Study Group.J Clin Oncol,2004,22:277-285.
[4]
Li m J S,Ki m M J,Yun M J,et al.Co mparison of CT and 18F-FDG PET f or Detecting Peritoneal Metastasis on the Preoperative Evaluation for Gastric Carcino ma.Korean J Radiol,2006,7:249-256.
[5]
Kubota K,Matsuzawa T,Amemiya A,et al.Imaging of breast cancer with[18 F].fluorodeoxyglucose and positron emmi msion to mography.J Comput Assit Tomogr,1989,13:1097-1098.
[6]
Avril N,Menzel M,Dose J,et al.Gluocose metabolis m of breast cancer assessed by 18 F-FDG PET:histologic and i mmunohistoche mical tissue analysis.J Nucl Med,2001,42:9-16.
[7]
Ueda S,Tsuda H,Asakawa H,et al.Clinicopathological and prognostic relevance of uptake level using 18 F-fl uorodeoxygl ucose positr on e mission to mography/co mputed to mography f usion i maging(18 F-FDG PET/CT)in pri mary breast cancer.Jpn J Clin Oncol,2008,38:250-258.
[8]
Avril N,RoséC A,Schelling M,et al.Breast i maging wit h positr on e mission to mography and fluorine-18 fluorodeoxygl ucose:use and li mitations.J Clin Oncol,2000,18:3495-3502.
[9]
邵婉仪,顾雅佳,贺锋.乳腺原发性非何杰金淋巴瘤钼靶X 线及MRI影像表现:附3例报告及文献复习.实用放射学杂志,2005,21:1090-1093.
[10]
reco M,Crippa F,Agresti R,et al.Axillar y ly mph node staging in breast cancer by 2-fl uor o-2-deoxy-D-glucose-positron emission to mography:clinical evaluation and alter native management.J Natl Cancer Inst,2001,93:630-635.
[11]
hae BJ,Bae J S,Kang BJ,et al.Positron emission to mography-co mputed to mography in the detection of axillary ly mph node metastasis in patients wit h earl y stage breast cancer.Jpn J Clin Oncol,2009,39:284-289.
[1] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[2] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[3] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[4] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[5] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[6] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[7] 程燕妮, 樊菁, 肖瑶, 舒瑞, 明昊, 党晓智, 宋宏萍. 乳腺组织定位标记夹的应用与进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 361-365.
[8] 涂盛楠, 胡芬, 张娟, 蔡海峰, 杨俊泉. 天然植物提取物在乳腺癌治疗中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 366-370.
[9] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[10] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[11] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[12] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[13] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
[14] 陈倩倩, 袁晨, 刘基, 尹婷婷. 多层螺旋CT 参数、癌胚抗原、错配修复基因及病理指标对结直肠癌预后的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 507-511.
[15] 张立俊, 孙存杰, 胡春峰, 孟冲, 张辉. MSCT、DCE-MRI 评估术前胃癌TNM 分期的准确性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 519-523.
阅读次数
全文


摘要